05919756 is referenced by 6 patents and cites 11 patents.

The present invention is directed to amides of antibiotic A82846B (also known as chloroorienticin A), and of N.sup.4 -derivatives of A82846B. The present amide compounds are useful as antibacterials, especially for the control of gram positive bacteria; the compounds are particularly useful for the control of resistant bacterial strains, such as vancomycin-resistant-enterococci ("VRE").

Title
Amides
Application Number
8/847069
Publication Number
5919756
Application Date
May 1, 1997
Publication Date
July 6, 1999
Inventor
Mark James Zweifel
Indianapolis
IN, US
Nancy June Snyder
Charlottesville
IN, US
Michael John Rodriguez
Indianapolis
IN, US
Robin David Grey Cooper
Indianapolis
IN, US
Agent
Arlene K Musser
Assignee
Eli Lilly and Company
IN, US
IPC
C07K 9/00
C07K 7/00
A61K 38/08
A61K 38/12
View Original Source